The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia temporary Total Artificial Heart.

UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality outcomes. The goal of the study was to uncover several trends related to high-priced physician preference items (PPIs). Utilization of PPIs — which can account for 30 to 40 percent of a hospital's supply expenses — at 10 academic medical centers, focusing on procedures utilizing orthopedic implants, coronary and peripheral stents and cardiac valves.

Mobile Heartbeat announced it will be demonstrating its MH-CURE communication and workflow smartphone application at the 2015 Healthcare Information and Management Systems Society (HIMSS) annual conference, April 13-15, 2015, in Chicago.

A new KLAS report on business intelligence (BI) found that healthcare organizations are looking for BI vendors with industry expertise and content to handle the growing complexities of data management. The report — entitled Health Analytics 2015: Moving toward the Continuum of Care — stresses that in-organization data is only a part of the picture and that data aggregation capabilities are more important than ever before.